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The complete three-dimensional structure in methanol of an
amphipathic a-helical peptide, that has been designed by
taking into account the three-dimensional structures of small
haemolytic peptides, secondary structure prediction
algorithms and the well documented literature on a-helix
stabilizing factors, has been elucidated by two-dimensional
NMR spectroscopy. Initially various two-dimensional spectra
(COSY, TOCSY, and NOESY) allowed the complete
sequence specific assignment of all signals in the 'H
spectrum. Consequently trial structures were generated which
were then subjected to molecular dynamics simulations using
121 NOE-derived distances and 25 vicinal coupling constant
values as structural restraints to give a final set of calculated
structures. These structures are in complete agreement with
the results of a circular dichroism study and reveal that the
peptide adopted a highly ordered a-helical conformation.
Details of the structure which throw light on future peptide/
protein design are discussed.
Key words: amphipathic a-helix/haemolytic peptide/NMR struc-
ture/secondary structure design
Introduction
Currently one of the unresolved key problems in molecular
biology is the understanding of the relationship between the
primary amino acid sequence of a protein or peptide and its three-
dimensional structure. The contribution of stabilizing forces
which determine the secondary and tertiary structure can best
be studied by the synthesis of small polypeptides that are designed
to adopt a specific desired conformation. Experimental structure
elucidation, either spectroscopically or crystallographically,
allows an assessment of the accuracy of the model construction
and an analysis of the contribution of structure stabilizing factors.
Our limited understanding of how proteins or peptides fold into
their specific conformation makes the use of short and easily
accessible synthetic peptides a powerful tool (Wright et al., 1988)
and can reduce the complexity of such systems by permitting
the selective examination of only one structural building block
(e.g. an a-helix). The fact that short linear peptides in isolation
are capable of adopting a stable a-helical conformation is of
considerable importance not only for the initiation of the protein
folding process but also because it validates the de novo design
of peptides with tailored structures and novel properties
(DeGrado, 1988; DeGrado etai, 1989). Designing helical
peptides is greatly facilitated by the existence of detailed
information about helix stabilizing factors (Shoemaker et al.,
1987) and about the relative helix forming propensities of the
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various amino acid residues (Chou and Fasman, 1974; Argos
and Palau, 1982; Palau et al., 1982).
A Helical Erythrocyte Lysing Peptide (HELP) with a length
of 26 residues, having a stable, amphiphilic, a-helical structure,
was designed using secondary structure prediction methods and
molecular modelling techniques (see Moser, 1992). Well
characterized lytically active peptides were taken as the main
structural template and together with the results from modelling
studies the amino acid sequence produced by the design strategy
was synthesized by the Merrifield solid-phase peptide synthesis
method. HELP induced pH-triggered cell disruption using human
erythrocytes as targets, as would be expected from a surface-
active amphiphilic helix.
The circular dichroism (CD) spectrum of HELP is typical of
an all a-helical peptide and highly suggestive of the presence
of a unique folded, helical structure (Greenfield and Fasman,
1969) with the value of [0]222 corresponding to a helix content
of -100% (Provencher and Glockner, 1981). In spite of the
similarity of CD spectra recorded in both aqueous and methanolic
solutions (see Moser, 1992) the NMR spectra of HELP in the
latter solvent showed drastically enhanced spectral resolution.
Thus methanol stabilizes the monomeric helical structure whereas
the peptide tends to form an aggregated helical state in aqueous
solution (see Moser, 1992). Hence the complete three-
dimensional structure of HELP dissolved in methanolic solution
was elucidated by high-resolution 2D 'H-NMR-studies and
molecular dynamics (MD) simulations.
Materials and methods
Peptide synthesis and sample preparation
HELP was synthesized by the Merrifield solid-phase peptide
synthesis method using /ert-butyloxycarbonyl-chemistry on np-
methylbenzhydrylamine resin in order to obtain a C-terminal
amide. The synthetic peptide was purified by reverse-phase
HPLC and its homogeneity was confirmed by amino acid
composition analysis, complete sequence analysis and FAB mass
spectral analysis. For the NMR-measurements one sample of
5.5 mg HELP was dissolved in 500 fil CD3OD (100% D,
Janssen Chimica, Nettetal, Germany) to which 1.5 /d DC1/D2O
(2% DC1) was added. A second sample consisted of 7 mg peptide
dissolved in 500 fil CD3OH (Merck, Sharp and Dohme
Isotopes) with the same amount of HC1/H2O added.
Light scattering experiments
Light scattering experiments were performed on 1 mM and
4.5 mM methanolic solutions of the peptide using the system
ALV-3000 (ALV Laservertriebsgesellschaft mbH, Langen,
Germany). The correlation functions were analysed with the help
of the program CONTIN (Provencher, 1982). The observed size
distributions were bimodal. A first peak corresponding to the
solubilized peptide co-existed with a second peak indicative of
dust or particle aggregates at least an order of magnitude larger.
As the scattered intensity is proportional to the square of the
molecular weight of the scatterers, the latter represent an
insignificant contamination without any relevance. The
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hydrodynamic radius was obtained from the third moment of the
distribution of the first peak. The values of 1.4 nm ± 0 . 3 nm
for the first sample and 1.2 nm ± 0.2 nm for the second sample
are consistent with a non-aggregated state of the peptide under
these conditions.
NMR experiments
NMR spectra were recorded on a BRUKER AM 600 spectro-
meter with time proportional phase increment (Redfield and
Kunz, 1975) for quadrature detection in the t|-dimension and at
temperatures between 277 K and 297 K. The temperature was
adjusted using a stream of nitrogen gas which was precooled in
a heat exchanger immersed in a thermostated liquid bath (Haake
GmbH, Karlsruhe, Germany). Spectra were referenced internally
with the residual signal of the methyl group of methanol set to
3.35 p.p.m. relative to 2,2-dimethyl-2-silapentanesulfonate
(DSS). ID NMR spectra recorded with peptide concentrations
between 0.3 mM and 4.5 mM showed no concentration-
dependent chemical shifts of the amide protons that would be
indicative of peptide aggregation under these conditions.
A phase-sensitive COSY-spectrum (Marion and Wiithrich,
1983) was recorded in conjunction with a NOESY-spectrum
(Jeener etai, 1979; Macura etai, 1981) on the CD3OD-
sample as part of the COCONOSY-experiment of 277 K
(Haasnoot etai, 1984; Gurevich etai, 1984). A double-
quantum filtered COSY-spectrum (Ranee et al., 1983) was
acquired at the same temperature with the peptide dissolved in
CD3OH. With the same sample a 2D TOCSY was recorded in
the 'CLEAN' version as described (Griesinger et al, 1988) with
the MLEV-17 mixing sequence (Bax and Davis, 1985; Davis
and Bax, 1985) but without the trim pulses. The total mixing
time was 100.2 ms. NOESY-spectra were acquired with the usual
pulse sequence (90-t)-90o-T—90°—acq) with mixing times
ranging from 60 to 240 ms. In all measurements the solvent
resonance line was irradiated during the relaxation delay ( Is )
and additionally during the mixing time of the NOESY-
experiments. All spectra were recorded using Ol/O2-phase
coherence (Zuiderweg etai, 1986).
To evaluate 3JHN-HCTvalues a ID-spectrum with a high digital
resolution was recorded, zero-filled to 64 k real data points,
multiplied by a Gaussian window and Fourier-transformed. For
overlapping resonance lines the coupling constants were extracted
from the 2D-COSY-DQF-spectrum. For all 2D-spectra typical-
ly 512 ti-increments were used with 64 scans sampled per
increment with a spectral width of 8064 Hz for both dimensions.
The data were transferred to an ASPECT X32 computer for 2D-
Fourier transformation and phase correction yielding data
matrices of Ik * Ik real data points for COSY-DQF and NOESY
and 2k * Ik for CLEAN TOCSY. The assignment of the cross-
peaks was greatly facilitated by the program AURELIA (Neidig
and Kalbitzer, 1990), which was also used for the determination
of the volumes of the NOE cross-peaks. Their intensities were
classified into five groups and translated into distances by an
empirical calibration of cross-peaks arising from known distances
within regular secondary structures (Billeter etai, 1982).
Distance restraints were used as upper bounds with appropriate
corrections for methyl groups or methylene protons which were
treated as pseudo-atoms (Wuthrich etai, 1983).
Restrained molecular dynamics simulations
Restrained molecular dynamics simulations and analysis of the
resulting structures were carried out on a TRACE (Multiflow
Corp.) mini-supercomputer using the GROMOS software
package (van Gunsteren and Berendsen, 1987). Creation of the
peptide in an extended configuration and display of structures
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was accomplished using the GBF-program BRAGI (Schomburg
and Reichelt, 1988) running under UNIX on a Hewlett Packard
Graphics System 9000. The approach for the creation of the initial
'pseudo-random' structures was influenced by Nilges et al.
(1988), whereas the protocol that was used for the main part of
the structure calculations was adopted from Bazzo et al. (1988)
and Klaus et al. (1991).
The initial structures for the molecular dynamics calculations
were created as follows. The peptide, in an extended conforma-
tion with all backbone angles artificially set to 180°, was subjected
to energy minimization to relieve the internal strain. Molecular
dynamics runs without restraints and with velocities taken from
a Maxwellian distribution corresponding to temperatures between
900 K and 1350 K were performed for time periods between
3 ps and 6 ps. These structures were energy minimized and used
as input for the calculations with restraints. Each one of these
starting structures was subjected to energy minimization using
500 steps of steepest descent with a small force constant of 200 kJ
mol"1 nm"2 for the distance restraints and 10 kJ mol"1 for the
dihedral restrains. This was followed by 2 ps of MD at 290 K
using the same force constants. The calculations were continued
at 1000 K with force constants set to 500 kJ mol"1 nm"2 and
35 kJ mol"1 for 4 ps and with values of 1000 kJ mol"1 nm"2
and 70 kJ mol"1 for another 4 ps. For the rest of the calcula-
tions the force constant for the distance restraints was set to
1500 kJ mol"1 nm"2. 3 ps of cooling to 600 K were followed
by 3 ps of dynamics, 2 ps cooling to 290 K and 30 ps of dynamics
at this temperature. During the 'high temperature stage' between
600 K and 1000 K the peptide bonds were additionally restrained
to prevent ds/fra/w-isomerizations. For the last 20 ps of each
run, which were used for analysing the resulting structure, a force
constant of 3000 kJ mol"1 nm"2 for the distance restraints was
applied. The cutoff radius for calculating non-bonded interactions
was set to 0.8 nm for both energy minimization and molecular
dynamics with a list of interactions updated every 10 cycles. To
constrain bondlengths the SHAKE algorithm was used allowing
a time step of 1 fs for the simulations.
Results
An expansion showing the amide region of the 'H NMR
spectrum of HELP is given in Figure 1. Most of the signals are
clearly resolved and allow direct measurement of the 3JHN-HCT
coupling constants. These, as listed in Table I, are a strong
indication of a helical secondary structure of the peptide.
Assignment of spin systems
The TOCSY-spectrum (Figure 2) with a 100 ms mixing time
shows the correlation of ten amide protons with methyl-groups
resonating around 1.0 p.p.m. which can only arise from leucine
spin-systems. The only other methyl-bearing amino acids present
in the peptide—Thr4 and Thr7—can be distinguished from the
leucines as the Thr-amide proton shows characteristic cross-peaks
in the 'fingerprint region' with both its a- and /3-CH. The NH
of Gly3 is readily assigned as it is the only proton visible at T
= 290 K which shows correlations with just two others at 3.86
and 4.01 p.p.m. This is confirmed by inspection of the COSY
spectrum where a cross-peak between both Ca-protons of Gly 1
can be observed. The NH of Glyl is observed only in spectra
recorded at T = 277 K where it resonates at 8.28 p.p.m. Both
Phe-residues are assigned based on their cross-peak pattern which
is typical of AMX-spin systems, and are readily correlated with
their amide protons in the TOCSY spectrum. This spectrum also
gives the total correlation of the 'long side chain' protons of the
two Lys and two Arg residues with their respective NHs. This
NMR structure of a designed a-helical peptide
Gin 26
Leu 2
ppm 9.1 9.0 8.9 8.8 B.7 8.6 8.5 8.4 8.3 8.2 8.1
1 l
8.0 7.9 7.8
Fig. 1. 'H NMR spectrum of 4.5 mM HELP in CD3OH recorded at 600 MHz and at a temperature of 290 K. Prior to Fourier transformation the data were
multiplied by a Gaussian window function.
leaves six amide protons which belong to the peptide's four Glus
and two Gins. Four of them resonate between 8.45 p.p.m. and
8.48 p.p.m. whereas the others are located at 7.81 p.p.m. and
7.99 p.p.m. This implies that the first group comprises the four
Glu-NHs and the second the NHs of the Gins. This finding is
confirmed in the course of the sequence specific assignment of
the amide protons.
Sequence specific assignment
Figure 3 shows NOE connectivities between the amide protons
of adjacent residues. The assignment starts with the highest field
shifted amide proton at 7.81 p.p.m. which has only one cross-
peak with the NH at 7.99 p.p.m. As both of these are of the
Glx-type they are assigned to the C-terminal Gln26 and Gln25,
respectively. The chain of NH-NH-connectivities can be followed
up the backbone to Phel9. Another string of NOEs starts with
Leu2 (or Glyl in the spectrum recorded at 277 K) on the N-
terminal side of the peptide and extends to Leu9. Having assigned
Phel9, the remaining Phe-residue must be number 11 in the
chain, which shows NH-NH-NOE-cross-peaks with one Glu
(which must be Glu 10) and Leu 12. The latter has a cross-peak
with another Leu, Leul3. This leaves the 'core' of the peptide,
which comprises Glu 14 to Glu 18, whose amide protons all
resonate between 8.40 p.p.m. and 8.55 p.p.m. Cross-peaks
between these resonances are best seen in the NOESY recorded
in CD3OD at 277 K. In this spectral region there are cross-peaks
connecting a segment of Glu-Leu-Leu-Glu. Their sequence
specific assignment remains ambiguous in the first instance,
because of the inherent symmetry of this peptide. However, there
is one weak cross-peak between Leu20 and a Glu-residue which
is interpreted as a contact between the amide protons of Leu20
Table I. 3JHN-HO a n c ' corresponding dihedral angles <p and * for HELP in
CD3OH. < ¥ " > M D and < * > M D a r e the values of the dihedral angles as
an average over the molecular dynamics analysis runs
Residue NH-CaH <«»MD
Glyl
Leu2
Gly3
Thr4
Leu5
Leu6
Thr7
Leu8
Leu9
Glu 10
Phell
Leul2
Leul3
Glu 14
Glu 15
Leul6
Leul7
Glu 18
Phel9
Leu20
Lys21
Arg22
Lys23
Arg24
Gln25
Gln26
—
3.8
5.5
4.4
3.9
4.3
4.0
4.6
4.4
4.1
4.1
4.3
4.0
4.3
3.9
4.3
4.2
4.2
3.9
4.0
4.0
3.9
3.9
4.0
4.3
6.0
7.1
—
-57
-70
-62
-57
-61
-58
-63
-62
-59
-59
-61
-58
-61
-57
-61
-60
-60
-57
-58
-58
-57
-57
-58
-61
-74
-83
—
-55.9
-58.5
-62.5
-59.8
-59.0
-64.2
-61.9
-60.4
-59.6
-60.7
-60.4
-60.4
-59.8
-60.3
-59.6
-59.6
-58.0
-61.4
-59.9
-60.5
-58.2
-60.5
-62.8
-74.1
-84.0
-141.3
-37.9
-51.9
-40.1
-45.1
-46.6
-39.7
-44.3
-43.3
-45.6
-45.4
-43.2
-47.0
-43.5
-43.4
-48.4
-43.0
-49.3
-43.3
-43.3
-45.9
-42.0
-37.8
-39.0
-11.1
61.4
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Fig. 2. NH (F2 axis)-aliphatic (F, axis) region of a CLEAN TOCSY-spectrum of 4.5 mM HELP in CD3OH recorded at 290 K with a mixing time of
100.2 ms. The spin systems are indicated by continuous lines.
and Glul8. This allows further the unambiguous assignment of
the fragment mentioned above as Glul8-Leul7-Leul6-Glul5
leaving one NH unassigned which must be Glul4. This is
consistent with the observation of NOEs between the Ca-proton
of Phel 1 and both the NH of Glul4 and Glul5 as well as with
other NOEs in the fingerprint region and in other parts of the
spectrum. Table II lists the assigned proton resonances of the
peptide, and a summary of the observed NOEs is given in
Figure 4. The predominance of leucine and glutamic acid residues
in the sequence gives rise to some degeneracies in the proton
chemical shifts resulting in overlap of cross-peaks. This effect
is especially severe in the spectral regions where NOESY peaks
between Ca-protons and CB-protons respectively and NH-
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protons of adjacent residues are observed. For the same reason
a stereospecific assignment of methylene protons and methyl
groups was not feasible.
Secondary structure of HELP
The NOESY spectra of HELP show all the patterns that are
characteristic of an a-helical arrangement of the peptide
backbone. Starting with Leu2 and extending up to Gln25, strong
or medium strong NOEs corresponding to distances d ^ are
observed between most of the adjacent amide protons, as shown
in Figure 3. Some of the NOEs that are not seen in this figure,
but are documented in Figure 4, are taken from NOESY spectra
recorded at a lower temperature or from cross-sections through
NMR structure of a designed a-helical peptide
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Fig. 3. NH-NH region of a NOESY-spectrum of HELP in CD3OH at 290 K with a mixing time of 240 ms. Cross-peaks between the amide protons are
labelled with the sequence positions of the residues. Sequential connectivities are indicated by continuous lines.
corresponding rows and columns in the case of cross-peaks close
to the diagonal. The presence of both consecutive medium-range
NOEs daN (i, i+3) and da(3(i, i + 3) throughout the sequence is
another strong indication that the proposed secondary structure
was accomplished. The aforementioned predominance of leucine
and glutamic acid residues in the peptide explains also why the
observation of medium-range NOEs da)3(i, i+3) is not complete.
The 3JHN-Ha coupling constants provide further evidence of a
helical fold, as a series of three or more constants smaller than
6 Hz is diagnostic of that structure element (Wuthrich, 1986).
With values smaller than 5 Hz, as are observed from Glyl to
Arg24, they are suggestive of a very large population of helical
structures of HELP in methanolic solution. Based on similar
considerations as given in Bradley et al. (1990) and with the same
assumption of a two-state model with a helical and a random coil
arrangement of the peptide backbone, we can estimate that the
time-averaged helical population for residues 1 —24 is more than
80%.
Molecular dynamics simulations
For the actual structure determination a total of 121 NOE-derived
distances (70 of them being inter-residue ones) were incorporated
in the GROMOS force field using the usual semi-harmonic
potential for the distance information. In addition 25 dihedral
angle restraints were included based on the calibration curve
between 3JHN-Ha a nd t n e a ngl e <f> (pardi et al., 1984). Attempts
to start the calculations with an extended conformation of the
peptide resulted only occasionally in reasonable final structures.
A better approach using the 'random' structures created as
described in Materials and methods, gave more satisfying results
as cis/trans isomerizations of peptide bonds were less frequent.
About 50 of these structures were subjected to molecular
dynamics runs covering the time span between 0 ps and 23 ps.
Structures which then showed more than three severe violations
of the inter-residue distance restraints (> 0.05 run) were discarded
as it was found that in the further course of the simulations these
restraints could not be satisfied. Seven configurations with few,
minor violations of the distance restraints and all showing helical
structures were subjected to a final analysis. The numbers of
distance violations together with the relevant energies after energy
minimizing are listed in Table m. The energy values for the
distance (Edr) and dihedral (Edlr) restraints are reasonably low,
as well as the values for the total energy (E,ot). The only
severely violated distance restraint in structures II and IV to VI
is the intra-residue one between the NH of Thr7 and the /3-proton
of the same amino acid. A possible reason for this will be
discussed below.
Hydrogen bonds within HELP
As a check of the helical folding of HELP, the formation and
breaking of hydrogen bonds was monitored during the analysis
of the molecular dynamics runs. Table IV lists all hydrogen bonds
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Table II.
Residue
Glyl
Leu2
Gly3
Thr4
Leu5
Leu6
Thr7 .
Leu8
Leu9
GlulO
Phell
Leu 12
Leul3
Glul4
Glul5
Leu 16
Leu 17
Glul8
Phel9
Leu20
Lys
Arg22
Lys23
Arg24
Gln25
Gln26
CONH2
'H Chemical shifts (in p.p.m.)
NH
8.28
9.14
8.91
8.18
7.97
8.31
8.02
8.11
8.42
8.45
8.49
8.59
8.45
8.47
8.47
8.40
8.55
8.48
8.53
8.64
8.39
8.21
8.32
8.11
7.99
7.81
7.59, 6.90
of HELP in CD3OH at T
H«
4.02, 3.85
4.24
4.01, 3.86
4.10
4.13
4.14
3.91
4.20
4.14
4.07
4.37
4.10
4.12
4.00
3.97
4.19
4.11
4.08
4.23
3.89
3.91
4.10
3.98
4.07
4.11
4.19
= 290 K relative to DSS.
1.72, 1.72
4.32
1.88, 1.79
1.89, 1.74
4.32
1.89, 1.84
1.75, 1.75
2.38, 2.18
3.34, 3.34
2.06, 2.06
1.92, 1.92
2.42, 2.11
2.25, 2.00
1.82, 1.89
1.60, 1.96
2.37, 2.13
3.44, 3.35
2.07, 1.54
2.00, 2.00
2.00, 2.00
1.74, 1.74
2.01, 2.01
2.14, 2.14
2.18, 2.18
The NH of Gly 1 is only observed at 277 K
1.73
7-CH3 1.31
1.79
1.74
7-CH3 1.22
2.00
1.98
2.68, 2.47
Ring: 7.19 7.26 7.31
1.66
1.79
2.71, 2.71
2.09, 2.34
2.00
2.06
2.61, 2.54
Ring: 7.19 7.26 7.31
2.10
1.42, 1.42
1.84, 1.71
1.26, 1.26
1.84, 1.71
2.63, 2.34
2.60, 2.35
Others
6-CH3 1.04, 1.00
5-CHj 1.03, 0.97
6-CH3 1.01, 0.96
5-CH3 1.02, 0.97
5-CH3 0.98, 0.98
5-CHj 1.00, 1.00
5-CH3 0.99,
0.99
5-CH3 1.04, 0.98
3-CH3 0.98, 0.96
6-CH3 1.00, 1.00
6-CH2 1.70, 1.70
e-CH2 2.94, 2.94
6-CH2 3.25, 3.25
e-NH 7.48
5-CH2 1.55, 1.55
e-CH2 2.88, 2.79
8-CH3 3.18, 3.24
e-NH 7.54
6-NH2 7.98, 7.04
5-NH2 7.60, 7.66
dN N( i . i
daN(i>3)
dap(i.i + 3)
JNH-C_H
1 3 5 7 9 11 13 15 17 19 21 23 25
G L 6 T L L T L L E F L L E E L L E F L K R K R Q Q
38 44 39 4.3 40 46 44 41 41 43 40 43 39 43 42 42 39 40 40 39 39 40 43 60 71
Fig. 4. Summary of the inter-residue NOEs of HELP. The heights of the bars correspond to the intensities of the NOEs. An asterisk indicates that no NOE
could be observed due to overlap of the signals.
occurring in more than 10% of the total analysis time and
averaged over all structures. The occupancy of more than 80%
of H-bonds between the amide proton of residue i and the
carbonyl oxygen of residue i —4 for Leu6 and from Leu8 up to
Lys23 gives clear evidence for the presence of a helical secondary
structure in this core region of HELP. The somewhat lower
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populated hydrogen-bond at Leu5 is as expected as there will
be some unravelling of the helix at the N-terminus. Thr7 deserves
special attention as there are three H-bonds which are significantly
populated. With an occurrence of 54.3%, the expected H-bond
between the amide proton of this amino acid and the carbonyl
oxygen of Gly3 is markedly underrepresented as compared to
NMR structure of a designed a-helical peptide
Table m . Energies and distance restraints violations of the seven final
structures (m kJ mol~') using a force constant K,jr = 3000 kJ moP1 nm - 2
Table V. (A) RMS-deviations of the seven final structures versus an 'ideal
helix' averaged over all backbone atoms (in nm).
E,ola
p bbdr d >0.02 nm
I
II
III
rv
V
VI
VII
2068.9
2080.7
1998.8
2091.8
2045.6
2058.0
2031.6
11.2
12.5
22.9
10.5
15.8
12.9
7.3
2.9
3.4
4.7
2.7
9.2
4.2
2.8
aE,ol, total energy.
bEdr, energy associated with the distance restraints.
cEd|r, energy associated with the dihedral restraints.
Table IV. Hydrogen bonds within HELP averaged over all seven final
structures as a result of the last 20 ps of the molecular dynamics runs with
more than 10% occurrence
Donor Acceptor Occurrence (in
Thr4 NH
Leu5 NH
Leu6 NH
Thr7 NH
Thr7 O7H
Thr7 O7H
Leu8 NH
Leu9 NH
GlulO NH
Phell NH
Leu 12 NH
Leul3 NH
Glul4 NH
Glul5 NH
Leul6 NH
Glul8 NH
GU1I8 Of2H
Phel9 NH
Leu20 NH
Lys21 NH
Arg22 NH
Lys23 NH
Lys23 NH
Arg24 NH
Arg24 NH
Gln25 NH
Gln25 NH
Gln26 NH
Gln26 NH
Gln26 NH
Gln26 Ne2H
Gln26 Ne2H
Gln26 CONH,
Glyl O=C
Glyl O=C
Leu2 O=C
Gly3 O=C
Thr4 O=C
Gly3 O=C
Thr4 O=C
Leu5 O=C
Leu6 O=C
Thr7 O=C
Leu8 O=C
Leu9 O=C
GlulO O=C
Phell O=C
Leul3 O=C
Glul4 O=C
Glul4 O,,
GlulS O=C
Leul6 O=C
Leul7 O=C
GU1I8 O=C
Phel9 O=C
Leu20 O=C
Leu20 O=C
Lys21 O=C
Lys21 O=C
Arg22 O=C
Arg22 O=C
Lys23 O=C
Arg24 O=C
Lys23 O=C
Arg22 O=C
Gln25 O=C
11.4
64.3
85.7
54.3
12.9
11.4
72.9
85.7
84.3
88.6
84.3
87.1
92.9
90.0
85.7
90.0
17.1
80.0
87.1
85.7
87.1
78.6
12.9
70.0
20.0
62.9
17.1
44.3
20.0
18.6
18.6
14.3
24.3
the other (i, i -4) H-bonds. Instead one observes H-bonds
between the side chain OH of Thr7 as donor and the backbone
oxygen of Gly3 and Thr4, respectively, with a total occurrence
of 24.3%. This coincides with the intra-residue distance restraint
violation between the amide proton and the /3-proton of Thr7.
At the C-terminus, one observes besides the normal (i, i -4)
H-bonds H-bonds between residues i and i - 3 and i - 2 ,
respectively, a feature which occurs frequently at this end of a
helix. There is no evidence for an unravelling of the peptide,
but the C-terminus rather deviates from an ideal a-helix towards
a 3|0-helix.
res. 1-26 res. 3 -23 res. 5-21
5 (0.034)
3 (0.055)
7 (0.054)
3 (0.047)
5 (0.052)
4 (0.056)
2 (0.030)
I
II
III
rv
V
VI
VII
Total
0.094
0.125
0.144
0.226
0.095
0.137
0.114
0.134
± 0.042
0.074
0.084
0.085
0.121
0.060
0.101
0.087
0.087
±0.019
0.058
0.069
0.076
0.077
0.044
0.070
0.072
0.066
±0.012
Table V. (B) average of the pairwise RMS-deviations among the seven final
structures (in nm)
res. 1-26 res. 3 -23 res. 5-21
0.185
±0.078
0.127
±0.039
0.101
±0.027
As a further criterion for the correct helical folding of the
calculated structures, they were compared to an 'ideal' helix,
which was model-built on the graphics display and then energy
minimized. The root mean square (RMS)-deviations for them
averaged over the atoms of the backbone are given in Table V.
The mean value of 0.133 nm for all structures and summed over
all residues is reasonably low, and it decreases further to
0.066 nm when averaged only over residues 5—21. This might
be explained by some curvature which is common to all the
NMR-derived structures of this peptide. A backbone superposi-
tion of the seven final structures is shown in Figure 5.
Discussion
The actual determination of the three-dimensional structure of
the designed helical peptide HELP in methanolic solution gives
us the possibility to check on the principles underlying the design,
as described by Moser (1992).
Evidence for the proposed helical structure
Already the first one-dimensional 'H-NMR-spectrum of HELP
dissolved in CD3OD showed evidence for the proposed
secondary structure. The observation of J-coupling constants
around 4 Hz and the fact that nearly all amide protons showed
very slow exchange with the solvent protons indicated the
presence of a very stable, hydrogen-bonded helical arrangement
of the peptide in solution. The detailed analysis of the NMR-
spectra and the results of the molecular dynamics calculations
show indeed that at least residues 5-24 are arranged in an a-
helical structure. So we conclude that the criteria for the selec-
tion of the amino acids in the sequence, i.e. the helical propen-
sity and the hydropathy, were correct.
Global fold for HELP
Inspection of the final structures shows clearly that the proposed
amphiphilic arrangement of the side chains emerged as a
consequence of the folding of the peptide. Indeed, the polar side
chains of glutamic acid constitute the hydrophilic face, allowing
at least to a certain extent the formation of a hydrogen bond
between the side chain carboxylate groups of Glul5 and Glul8.
As intended the apolar Leu-residues occupy the hydrophobic face.
Additionally, one observes a slight bending of the helix axis
towards this side suggesting some clustering of the hydrophobic
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Fig. 5. Backbone representation of the seven final structures of HELP, superimposed for minimum RMS deviation between residues Gly3 and Lys23.
side chains. This may also be supported by a mutual residual
repulsion of the Glu side chains.
It is clear from our results the chosen length of 26 residues
is more than the minimum length for a peptide to adopt a stable
secondary structure. End effects do not seem to play such an
important role, especially in our design with the C-terminal a-
carboxyl group blocked by an amide group. Unravelling of the
helix is observed only at the N-terminus, where the first four
residues are involved. Based on the pattern of hydrogen bonds
the C-terminus shows a tendency towards formation of an even
more compact 3I0-helix. This arrangement compares very well
with the solution structure of the peptide toxin melittin (Bazzo
et ai, 1988), whose sequence served as a template for HELP
and from which the six C-terminal residues were taken over
unchanged.
The severe distance restraint violation within Thr7, as
mentioned above, can be explained in at least two ways. The
first explanation would be a misinterpretation of the NOE-derived
distance between the amide proton and the beta proton of this
amino acid. However, this can be ruled out as three of the seven
final structures do not show any violation of this restraint. The
second reason could be that the force constant for the distance
restraints was not high enough to counteract the energetically
favourable formation of a hydrogen bond between the carbonyl
oxygen of Gly3 and the side chain OH of Thr7. The latter locks
these structures in a slightly distorted conformation of the side
chain, for which there is no experimental evidence. This also
explains the observed lowered occurrence of the H-bond between
the amide proton of this residue and the carbonyl oxygen of Gly3,
which one would expect for a regular a-helix, and the existence
of an H-bond between the side chain oxygen of this threonine
and Gly3.
The dynamic properties of HELP—as manifested in the
formation and breaking of the hydrogen bonds observed during
the molecular dynamics simulations—correlate very well with
the estimate of the helical content as deduced from the population-
weighted average of the 3JHN-H« coupling constants. With this
determination at an atomic resolution of the three-dimensional
structure of a designed helical peptide, the peptide design circle
is closed. Having these results at hand, one can even go further
towards designing more sophisticated amphiphilic a-helices,
which could be used to tailor specific minienzymes with proposed
catalytic activities. HELP with its unexpected, extraordinarily
high stability when compared with other naturally occurring small
peptides may also be used as a valuable a-helix model enabling
the study of the initial folding of proteins and of the factors which
stabilize the three-dimensional structure.
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